Table 4 Prevalence of insulin resistance (%) according to various HOMA-IR cutoffs in cardio metabolic risk factors
|  |  |   Total(N = 3203) |   Prepuberty(N = 1084) |   Puberty(N = 2119) | ||
|---|---|---|---|---|---|---|
Cardiometabolic risk actors | 2.3 | 3.0 | 1.7 | 2.6 | 2.6 | 3.2 |
| Â | (ROC) | (>95th percentile in normal subjects) | (ROC) | (>95th percentile in normal subjects) | (ROC) | (>95th percentile in normal subjects) |
MS(ATP III) | 79.0 | 61.6 | 86.0 | 53.3 | 77.3 | 63.5 |
WC ≥ 90th percentile | 65.0 | 45.7 | 67.2 | 36.0 | 67.9 | 51.8 |
HDL-C ≤ 5th percentile | 61.9 | 44.0 | 62.9 | 32.3 | 58.3 | 42.6 |
TG ≥ 90th percentile | 59.9 | 42.5 | 67.7 | 38.9 | 55.1 | 42.2 |
FBG ≥ 5.6 mmol/L | 65.2 | 47.7 | 62.0 | 34.0 | 64.5 | 51.6 |
BP ≥ 95th percentile | 57.9 | 41.8 | 64.9 | 34.6 | 56.5 | 43.5 |